PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 25, 20262 citations

Exosome-mediated decay of unstable long extended precursors of human telomerase RNA is dependent on 5'-cap trimethylation.

View Full Paper
ASAniruddha SamajdarRARoberta AmatoJYJai Il Youn

Key Points

  • This research aims to investigate how posttranscriptional modifications affect the stability and degradation of human telomerase RNA (hTR).
  • Analyzed the role of TGS1-mediated 5'-cap trimethylation in hTR precursor degradation.
  • Assessed the impact of preventing 5'-cap trimethylation on nucleolar hTR precursor accumulation.
  • Examined the effect of 3'-end oligoadenylation by PAPD5 on mature hTR degradation.
  • 5'-cap trimethylation is crucial for targeting long hTR precursors for degradation.
  • Inhibiting 5'-cap trimethylation leads to the accumulation of 3'-end extended hTR precursors.
  • Combined inhibition of both 5'-cap trimethylation and 3'-end oligoadenylation significantly increases hTR levels in mutated cells.

Abstract

Mutations that impact maturation of human telomerase RNA (hTR) are common in telomere biology disorders. Here, we describe sequential posttranscriptional modifications that coordinate hTR biogenesis and decay. Initially, TGS1-mediated 5'-cap trimethylation targets long genomically extended hTR precursors for degradation. Prevention of 5'-cap trimethylation results in accumulation of nucleolar 3'-end extended precursors, evading MTR4 recognition and degradation by the exosome. In a second step, 3'-end oligoadenylation by PAPD5 promotes degradation of mature hTR, a process that remains dependent on 5'-cap modifications, as prevention of trimethylation inhibits decay of heavily 3'-end oligoadenylated molecules. Combined inhibition of 5'-cap trimethylation and 3'-end oligoadenylation synergistically increases hTR in cells harboring pathogenic mutations in telomerase. These data reveal a precise interplay between 5'- and 3'-end posttranscriptional modifications that dictate hTR fate and highlight the potential of RNA therapeutics for treatment of telomere biology disorders.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Samajdar et al. (2026) studied this question.

synapsesocial.com/papers/6975b1a9feba4585c2d6d214https://doi.org/10.1101/gad.353100.125
Ask AI
Helpful
Bookmark
Share
View Full Paper